Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
Oral drugs stimulating endogenous insulin production (insulin secretagogues) may have detrimental effects on breast cancer outcomes. The data presented shows the relationship between pre-existing insulin secretagogues use, adipokine profiles at the time of breast cancer (BC) diagnosis and subsequent...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-02-01
|
| Series: | Data in Brief |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235234091630720X |
| _version_ | 1818218079152242688 |
|---|---|
| author | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Zahra S. Fayazi Dan P. Gaile Alan Forrest Alice C. Ceacareanu |
| author_facet | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Zahra S. Fayazi Dan P. Gaile Alan Forrest Alice C. Ceacareanu |
| author_sort | Zachary A.P. Wintrob |
| collection | DOAJ |
| description | Oral drugs stimulating endogenous insulin production (insulin secretagogues) may have detrimental effects on breast cancer outcomes. The data presented shows the relationship between pre-existing insulin secretagogues use, adipokine profiles at the time of breast cancer (BC) diagnosis and subsequent cancer outcomes in women diagnosed with BC and type 2 diabetes mellitus (T2DM). The Pearson correlation analysis evaluating the relationship between adipokines stratified by T2DM pharmacotherapy and controls is also provided. This information is the extension of the data presented and discussed in “Insulin use, adipokine profiles and breast cancer prognosis” (Wintrob et al., in press) [1]. |
| first_indexed | 2024-12-12T07:18:03Z |
| format | Article |
| id | doaj.art-40006881597046f686e955946212c5f3 |
| institution | Directory Open Access Journal |
| issn | 2352-3409 |
| language | English |
| last_indexed | 2024-12-12T07:18:03Z |
| publishDate | 2017-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Data in Brief |
| spelling | doaj.art-40006881597046f686e955946212c5f32022-12-22T00:33:26ZengElsevierData in Brief2352-34092017-02-0110C23824710.1016/j.dib.2016.11.060Circulating adipokines data associated with insulin secretagogue use in breast cancer patientsZachary A.P. Wintrob0Jeffrey P. Hammel1George K. Nimako2Zahra S. Fayazi3Dan P. Gaile4Alan Forrest5Alice C. Ceacareanu6State University of New York at Buffalo, Department of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesCleveland Clinic, Department of Biostatistics and Epidemiology, 9500 Euclid Ave., Cleveland, OH 44195, United StatesState University of New York at Buffalo, Department of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesState University of New York at Buffalo, Department of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesState University of New York at Buffalo, Department of Biostatistics, 718 Kimball Tower, Buffalo, NY 14214, United StatesThe UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, Campus Box 7569, Chapel Hill, NC 27599, United StatesState University of New York at Buffalo, Department of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesOral drugs stimulating endogenous insulin production (insulin secretagogues) may have detrimental effects on breast cancer outcomes. The data presented shows the relationship between pre-existing insulin secretagogues use, adipokine profiles at the time of breast cancer (BC) diagnosis and subsequent cancer outcomes in women diagnosed with BC and type 2 diabetes mellitus (T2DM). The Pearson correlation analysis evaluating the relationship between adipokines stratified by T2DM pharmacotherapy and controls is also provided. This information is the extension of the data presented and discussed in “Insulin use, adipokine profiles and breast cancer prognosis” (Wintrob et al., in press) [1].http://www.sciencedirect.com/science/article/pii/S235234091630720XAdipokineInsulinSecretagogueBreast cancerDiabetesCancer outcomesCancer prognosis |
| spellingShingle | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Zahra S. Fayazi Dan P. Gaile Alan Forrest Alice C. Ceacareanu Circulating adipokines data associated with insulin secretagogue use in breast cancer patients Data in Brief Adipokine Insulin Secretagogue Breast cancer Diabetes Cancer outcomes Cancer prognosis |
| title | Circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| title_full | Circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| title_fullStr | Circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| title_full_unstemmed | Circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| title_short | Circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| title_sort | circulating adipokines data associated with insulin secretagogue use in breast cancer patients |
| topic | Adipokine Insulin Secretagogue Breast cancer Diabetes Cancer outcomes Cancer prognosis |
| url | http://www.sciencedirect.com/science/article/pii/S235234091630720X |
| work_keys_str_mv | AT zacharyapwintrob circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT jeffreyphammel circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT georgeknimako circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT zahrasfayazi circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT danpgaile circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT alanforrest circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients AT alicecceacareanu circulatingadipokinesdataassociatedwithinsulinsecretagogueuseinbreastcancerpatients |